Pharmacological analysis of negative allosteric modulation of the α7 nicotinic receptor by polyunsaturated free fatty acids
Abstract
The α7 nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel mediating cholinergic signaling. Its implication in neurological disorders and inflammation has spurred the development of synthetic effectors, either orthosteric agonists acting on the extracellular domain, or positive allosteric modulators (PAMs) acting at the transmembrane domain. In this context, endogenous polyunsaturated free fatty acids (PUFAs) were early recognized to modulate the receptor function, but their site of action remained unexplored. Here, we characterized a series of PUFAs by two-electrode voltage-clamp (TEVC) electrophysiology and used coarsegrained molecular dynamics (CG-MD) simulations coupled to mutational analysis to identify their binding sites. Data reveal that PUFAs are negative allosteric modulators (NAMs) whose strength depends on the length and degree of unsaturation of the hydrophobic tail and the polarity of the head group. Combined CG-MD and mutational data identified a major "structural" intrasubunit M1/M4 site which does not contribute to the NAM effect, and a minor intersubunit M3 + /M1-site where mutations strongly impair NAM activity. The M3 + /M1site overlaps with the site for synthetic PAMs, showing a common hotspot for positive and negative allosteric modulation with implications for drug design and functional regulation in physiological conditions.
Related
- The Endogenous Negative Allosteric Modulator, Lynx1, Inhibits Nicotinic Cholinergic Signaling in the Ventral Tegmental Area to Regulate Nicotine Reinforcement
- Allosteric modulation of YTHDFs by ellagic acid suppresses triple-negative breast cancer via non-canonical activation of the HIF-1α pathway
- Uncoupling of the allosteric signalling network in the β₁-adrenergic receptor by a negative allosteric modulator.
- Mechanistic basis of μ-opioid receptor allosteric modulation from molecular simulations
- The ganglioside profile of mouse brain does not respond to changes in dietary n-3 polyunsaturated fatty acid supply
BibTeX
@article{awad2026pharmacological,
title = {{Pharmacological analysis of negative allosteric modulation of the α7 nicotinic receptor by polyunsaturated free fatty acids}},
author = {Nour Awad and Jesse Sandberg and Nathalie Barilone and Margaux Lustig and Pierre-Jean Corringer and Grace Brannigan and Marie S Prevost},
journal = {Cellular and Molecular Life Sciences},
year = {2026},
month = oct,
doi = {10.1007/s00018-026-06498-2},
url = {https://hal.science/hal-05835768v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Pharmacological analysis of negative allosteric modulation of the α7 nicotinic receptor by polyunsaturated free fatty acids
AU - Nour Awad
AU - Jesse Sandberg
AU - Nathalie Barilone
AU - Margaux Lustig
AU - Pierre-Jean Corringer
AU - Grace Brannigan
AU - Marie S Prevost
PY - 2026
DA - 2026/10/22
JO - Cellular and Molecular Life Sciences
DO - 10.1007/s00018-026-06498-2
UR - https://hal.science/hal-05835768v1
AB - The α7 nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel mediating cholinergic signaling. Its implication in neurological disorders and inflammation has spurred the development of synthetic effectors, either orthosteric agonists acting on the extracellular domain, or positive allosteric modulators (PAMs) acting at the transmembrane domain. In this context, endogenous polyunsaturated free fatty acids (PUFAs) were early recognized to modulate the receptor function, but their site of action remained unexplored. Here, we characterized a series of PUFAs by two-electrode voltage-clamp (TEVC) electrophysiology and used coarsegrained molecular dynamics (CG-MD) simulations coupled to mutational analysis to identify their binding sites. Data reveal that PUFAs are negative allosteric modulators (NAMs) whose strength depends on the length and degree of unsaturation of the hydrophobic tail and the polarity of the head group. Combined CG-MD and mutational data identified a major "structural" intrasubunit M1/M4 site which does not contribute to the NAM effect, and a minor intersubunit M3 + /M1-site where mutations strongly impair NAM activity. The M3 + /M1site overlaps with the site for synthetic PAMs, showing a common hotspot for positive and negative allosteric modulation with implications for drug design and functional regulation in physiological conditions.
SN - 1420-682X
SN - 1420-9071
ER -